ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 351866 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 351866; 2) Community: the network communities that were significantly associated with the response to NSC 351866; 3) Molecule: the relationships between components within communities and NSC 351866; 4) MDR: the compounds that were significantly associated with the NSC 351866.

NSC Compound Enrichment Correlation
NSC 665564 Null 0.0108954273764103 0.34851487
NSC 666355 Null 0.0108954273764103 -0.21915191
NSC 672116 9-.alpha.-Acetoxyparthenolide 0.0108954273764103 0.41664054
NSC 681643 Camptothecin Derivative 0.0108954273764103 0.10875518
NSC 716951 Null 0.0108954273764103 0.41504459
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0108954273764103 0.34243732
NSC 736157 Null 0.0108954273764103 -0.17155031
NSC 748715 Null 0.0108954273764103 0.42372079
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.0138010872611484 -0.17327117
NSC 11232 Anisole-2-azo-.beta.-naphthol 0.0138010872611484 -0.23512381
Total:79  Current:23    [First] [Prev] [Next] [Last]